https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2024.0027
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Growing evidence indicates that severe tricuspid regurgitation (TR) is independently associated with adverse clinical outcomes. The prognostic benefit of isolated TR surgery remains unclear, and medical therapy for decompensated right heart failure alone cannot delay disease progression. TR assessment and management have substantially evolved in recent years. Currently, minimally invasive catheter-based techniques have emerged as a feasible and effective option for TR treatment in high-risk surgical patients. Transcatheter tricuspid valve edge-to-edge repair (T-TEER) has been proposed and applied as an interventional treatment for TR, and has yielded promising preliminary results. This review provides an overview of the current state of T-TEER.
CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications . Submissions may be made using ScholarOne Manuscripts . There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal ; or Facebook .
Peng Zhang, Binbin Liu and Xiang Chen et al. The Evolving Role of Transcatheter Tricuspid Valve Edge-to-Edge Repair in Tricuspid Regurgitation. CVIA. 2024. Vol. 9(1). DOI: 10.15212/CVIA.2024.0027
Cardiovascular Innovations and Applications